Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Pretreatment of serum for use in RBC antibody identification; by dilution

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86976 refers to the process of pretreating serum for the purpose of identifying red blood cell (RBC) antibodies through a method known as dilution. This procedure involves taking a blood sample and treating it with specific antigens. The treatment is performed by adding red blood cells that have already been coated with these antigens to a serum derived from the original blood sample. The key aspect of this code is that the serum must be diluted prior to the addition of the red blood cells. This dilution step is crucial as it prepares the serum for the subsequent identification of any antibodies present against the red blood cells. It is important to note that this code is distinct from other related procedures, such as CPT® Code 86977, which involves the addition of an inhibitor to neutralize a drug in the serum, and CPT® Code 86978, which pertains to the incubation of red blood cells and serum together before testing. Understanding the specific requirements and distinctions of these codes is essential for accurate medical coding and billing in laboratory settings.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 86976 is indicated for the identification of red blood cell antibodies in patients. This is particularly relevant in situations where there is a need to assess compatibility for blood transfusions, investigate hemolytic anemia, or evaluate immune responses related to blood group antigens. The identification of these antibodies is crucial for ensuring patient safety during transfusions and for managing conditions that may arise from incompatible blood types.

  • Blood Transfusion Compatibility This procedure is performed to ensure that the blood type of a patient is compatible with the donor blood, thereby preventing adverse reactions during transfusions.
  • Hemolytic Anemia Investigation It is used to investigate cases of hemolytic anemia, where the body destroys red blood cells faster than they can be produced, often due to the presence of antibodies against RBCs.
  • Immune Response Evaluation The procedure helps evaluate the immune response related to blood group antigens, which can be critical in various clinical scenarios.

2. Procedure

The procedure for CPT® Code 86976 involves several key steps that ensure the accurate identification of red blood cell antibodies. First, a blood sample is collected from the patient, which serves as the source of serum for the test. This serum is then subjected to a dilution process, where it is mixed with a diluent to reduce the concentration of antibodies present. This dilution is essential as it prepares the serum for the subsequent addition of red blood cells. After the serum has been adequately diluted, red blood cells that have been pre-treated with specific antigens are added to the serum. The interaction between the diluted serum and the antigen-coated red blood cells allows for the identification of any antibodies that may be present in the serum. The results of this procedure are critical for determining the appropriate course of action in transfusion medicine and for managing patients with potential blood compatibility issues.

  • Step 1: Blood Sample Collection A blood sample is collected from the patient, which will be used to obtain serum for testing.
  • Step 2: Serum Dilution The collected serum is diluted with a suitable diluent to prepare it for the addition of red blood cells.
  • Step 3: Addition of Antigen-Coated Red Blood Cells Red blood cells that have been coated with specific antigens are added to the diluted serum, allowing for the identification of antibodies.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 86976, the laboratory will analyze the interaction between the diluted serum and the antigen-coated red blood cells. The results will indicate the presence or absence of specific antibodies against the red blood cells. It is important for healthcare providers to review these results promptly, as they may influence decisions regarding blood transfusions or further diagnostic testing. Additionally, any necessary follow-up actions should be taken based on the findings, including potential additional testing or consultations with specialists in transfusion medicine. Proper documentation of the procedure and results is essential for maintaining compliance and ensuring accurate billing.

Short Descr RBC SERUM PRETX ID DILUTION
Medium Descr PRETX SERUM RBC ANTIBODY IDENTIFICATION DILUTION
Long Descr Pretreatment of serum for use in RBC antibody identification; by dilution
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
2011-01-01 Changed Short description changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"